The combination of PI3K/mTOR inhibitors with PD‐1 blockade effectively reinvigorated the exhausted T‐cell population, reinstating their effector function and leading to clonal hyper‐expansion of a cytotoxic CD8+ Teff population, ultimately resulting in partial or complete tumour responses. The gene discussed is CD8A; the disease is neoplasm.